TRENTON, N.J.—Drugmaker Merck & Co. said Monday that it now has 43 experimental drugs in mid-or late-stage testing—nearly double what it had before buying joint venture partner Schering-Plough Corp. last fall.
Generic drugmaker Teva Pharmaceutical Industries Ltd. said Tuesday it has appointed vice chairman Dr. Phillip Frost to serve as chairman of its board.
Generic drugmaker Teva Pharmaceuticals names vice chairman Frost as board chairman Teva Pharmaceutical Industries - Teva Pharmaceutical - Drug - Business - Generic drug
Generic drugmaker Teva Pharmaceutical Industries Ltd. said Tuesday it has appointed vice chairman Dr. Phillip Frost to serve as chairman of its board. The world's largest generic drugmaker by revenue...
MANASSAS, VA--(Marketwire - March 9, 2010) - Emerging World Pharma Inc. ( PINKSHEETS : EWPI ), an investor in generic based pharmaceutical companies manufacturing within developing nations, has provided an initial investment into a private generic pharmaceutical company located in West Africa. The investment would entitle Emerging World Pharma a percentage of profits obtained from an exclusive ...
Generic drugmaker Teva Pharmaceutical Industries Ltd. said Tuesday it has appointed vice chairman Dr. Phillip Frost to serve as chairman of its board. The world's largest generic drugmaker by revenue said Frost will replace Moshe Many, who had been serving as... Teva Pharmaceutical Industries - Business - Biotechnology and Pharmaceuticals - Pharmaceuticals - Manufacturing
By The Associated Press Generic drugmaker Teva Pharmaceutical Industries Ltd. said Tuesday it has appointed vice chairman Dr. Phillip Frost to serve as chairman of its board.
The state government of Andhra Pradesh is embarked upon a plan to launch a string of generic pharmacy stores in most districts of the state.
A senior Thai official voiced hope Monday for a WTO solution on the production of low-cost generic drugs, an issue that has stirred friction with Western companies.
In the 12 months ended September 2009, global prescription sales growth of generic drugs climbed by 7.7 per cent, up from 3.6 per cent in 2008.
